Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Advanced Oncotherapy
Life Sciences
On the home straight
By
Dr Martin Hall
15 Nov 2021
Tissue Regenix
Life Sciences
Faster-than-anticipated recovery
By
Dr Martin Hall
19 Oct 2021
Stay up-to-date with the latest research
Sign up to our newsletter
London Medical Laboratory
Life Sciences
Testing the market…clinically speaking
By
Dr Martin Hall
04 Oct 2021
Cizzle Biotechnology
Life Sciences
Keeping on-track
By
Dr Martin Hall
30 Sep 2021
Shield Therapeutics Plc
Life Sciences
September 2021 Investor Forum
By
Dr Martin Hall
21 Sep 2021
Incanthera Ltd
Life Sciences
September 2021 Investor Forum
By
Dr Martin Hall
21 Sep 2021
Diurnal Group Plc
Life Sciences
September 2021 Investor Forum
By
Dr Martin Hall
21 Sep 2021
Cizzle Biotechnology
Life Sciences
Strategic collaboration with SGSC
By
Dr Martin Hall
20 Sep 2021
Diurnal Group Plc
Life Sciences
All set for three pivotal trials
By
Dr Martin Hall
16 Sep 2021
Ulisse BioMed
Life Sciences
Molecular diagnostic game changer
By
Jason Streets
06 Sep 2021
Shield Therapeutics Plc
Life Sciences
Focused on US market penetration
By
Dr Martin Hall
20 Aug 2021
Prev
1
2
3
4
5
6
...
22
Next
